Xvivo Perfusion AB (publ) (STO: XVIVO)
Sweden
· Delayed Price · Currency is SEK 499.00
-3.00 (-0.60%)
Jan 9, 2025, 11:05 AM CET
Xvivo Perfusion AB Market Cap
Xvivo Perfusion AB has a market cap or net worth of 15.54 billion as of January 8, 2025. Its market cap has increased by 61.01% in one year.
Market Cap
15.54B
Enterprise Value
15.12B
Revenue
750.59M
Ranking
n/a
PE Ratio
75.40
Stock Price
499.00
Market Cap Chart
Since October 8, 2012, Xvivo Perfusion AB's market cap has increased from 371.69M to 15.54B, an increase of 4,082.22%. That is a compound annual growth rate of 35.60%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 110.31B |
| Sectra AB | 51.16B |
| Getinge AB | 50.21B |
| Camurus AB | 34.67B |
| Vitrolife AB | 29.49B |
| Medicover AB | 28.17B |
| Bonesupport Holding AB | 26.23B |
| Elekta AB | 23.99B |